Tag: investing in Core One
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
Psychedelic Expert Core One Labs Reports Milestone Acquisition
Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
Core One Labs Highlights Key Points from International Investor Call
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
